CorMedix (CRMD) Income towards Parent Company: 2012-2025
Historic Income towards Parent Company for CorMedix (CRMD) over the last 12 years, with Sep 2025 value amounting to $108.6 million.
- CorMedix's Income towards Parent Company rose 4002.28% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $163.0 million, marking a year-over-year increase of 496.27%. This contributed to the annual value of -$17.9 million for FY2024, which is 62.52% up from last year.
- As of Q3 2025, CorMedix's Income towards Parent Company stood at $108.6 million, which was up 433.49% from $20.3 million recorded in Q2 2025.
- Over the past 5 years, CorMedix's Income towards Parent Company peaked at $108.6 million during Q3 2025, and registered a low of -$14.5 million during Q1 2024.
- Over the past 3 years, CorMedix's median Income towards Parent Company value was -$6.3 million (recorded in 2023), while the average stood at $10.0 million.
- Per our database at Business Quant, CorMedix's Income towards Parent Company plummeted by 60.27% in 2023 and then skyrocketed by 4,002.28% in 2025.
- CorMedix's Income towards Parent Company (Quarterly) stood at -$7.8 million in 2021, then fell by 5.36% to -$8.2 million in 2022, then crashed by 42.18% to -$9.7 million in 2023, then spiked by 71.45% to $13.5 million in 2024, then soared by 4,002.28% to $108.6 million in 2025.
- Its last three reported values are $108.6 million in Q3 2025, $20.3 million for Q2 2025, and $20.6 million during Q1 2025.